Beyond Air (XAIR) Enterprise Value Growth (1y) (2016 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Beyond Air | 3.27 Mn | -6.59 Mn | 300,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -140.81% |
| Sep 30, 2025 | 65.47% |
| Jun 30, 2025 | 73.50% |
| Mar 31, 2025 | 81.22% |
| Dec 31, 2024 | 85.68% |
| Sep 30, 2024 | 22.63% |
| Jun 30, 2024 | 5.26% |
| Mar 31, 2024 | 50.40% |
| Dec 31, 2023 | 66.87% |
| Sep 30, 2023 | 38.27% |
| Jun 30, 2023 | 60.79% |
| Mar 31, 2023 | 21.98% |
| Dec 31, 2022 | 0.67% |
| Sep 30, 2022 | -18.16% |
| Jun 30, 2022 | -95.65% |
| Mar 31, 2022 | -140.23% |
| Dec 31, 2021 | -283.73% |
| Sep 30, 2021 | -118.07% |
| Jun 30, 2021 | -62.11% |
| Mar 31, 2021 | -38.50% |
| Dec 31, 2020 | -715.90% |
| Sep 30, 2020 | -849.34% |
| Jun 30, 2020 | -3,643.41% |
| Mar 31, 2020 | -223.04% |
| Dec 31, 2019 | -460.22% |
| Sep 30, 2019 | 51.60% |
| Jun 30, 2019 | -62.44% |
| Mar 31, 2019 | -967.80% |
| Dec 31, 2018 | 58.95% |
| Sep 30, 2018 | -29.49% |
| Jun 30, 2018 | 92.25% |
| Mar 31, 2018 | 89.66% |
| Dec 31, 2017 | -17,147.80% |
| Sep 30, 2017 | -18,685.00% |
| Jun 30, 2017 | -259,350.00% |
| Mar 31, 2017 | -23,703.33% |
| Dec 31, 2016 | 94.57% |